FGF21 and metabolic disease: A large, long-term, well-designed RCT or a multicenter collaborative RCT is warranted to provide deeper insights into the clinical benefits of FGF21 analogs on glycemic parameters, lipid profiles, and circulating ADP levels in different metabolic disorders.